This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Jardogs Advances Patient Engagement Platform With FollowMyHealth™ V1.5

SPRINGFIELD, Ill., Feb. 26, 2013 /PRNewswire/ --  Jardogs, a leading provider of patient engagement and health management solutions, has announced the newest release of its flagship product, FollowMyHealth™ Universal Health Record.

FollowMyHealth is a patient engagement solution that combines the value of a personal health record, the power of a patient portal and the connectivity of a health information exchange (HIE). Functionality enhancements for FollowMyHealth version 1.5 lay the groundwork for upcoming Meaningful Use requirements, while markedly expanding patient usability and enhancing the user experience.

"Named 'most-used, best-of-breed portal' by KLAS*, FollowMyHealth is adding significant value to the healthcare delivery process by supplying a solution that exceeds the expectations of both the provider and the patient," said Jim Hewitt, CEO, Jardogs. "Patients overwhelmingly want the type of online access to their health information that FollowMyHealth provides. And with Meaningful Use rules requiring patient portals, providers and organizations are in dire need of a solution that integrates with disparate EHRs to produce one comprehensive health record."

Steve Badger, CEO, The George Washington Medical Faculty Associates added, "With FollowMyHealth, our patients now have a single point of access that lets them communicate and connect with our physicians – anywhere, anytime. It's this type of solution that differentiates us in the market so we can continually provide the technological solutions our patients have come to expect at GWU-Medical Faculty Associates."

FollowMyHealth empowers providers to engage patients so they can access and manage their health and wellness information in a secure, online environment. Accessible by any computer, smartphone or tablet, patients can easily view test results, communicate with physicians, request appointments and prescription refills, pay bills and complete forms prior to a visit – 24 hours a day / 7 days a week.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs